ReviewGlobal cardiology science & practice2021

Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.

Ioanna Istampoulouoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.